“Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary Angioplasty by Pretreatment with High Dose Atorvastatin”, JMHSR, vol. 2, no. 1, Jan. 2025, doi: 10.62019/ms935p95.